Cover Image
市場調查報告書

藥物研發的資訊學市場規模與預測:各工作流程 (藥物研發、開發、鑑定及驗證、化驗開發、其他) 、各手法、各類服務,及2012∼2022年趨勢分析

Drug Discovery Informatics Market Size & Forecast By Workflow,(Discovery Informatics, Development Informatics, Identification & Validation Informatics Assay Development Informatics, and Others), By Mode, By Services, And Trend Analysis From 2012 To 2022

出版商 Grand View Research, Inc. 商品編碼 355254
出版日期 內容資訊 英文 78 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
藥物研發的資訊學市場規模與預測:各工作流程 (藥物研發、開發、鑑定及驗證、化驗開發、其他) 、各手法、各類服務,及2012∼2022年趨勢分析 Drug Discovery Informatics Market Size & Forecast By Workflow,(Discovery Informatics, Development Informatics, Identification & Validation Informatics Assay Development Informatics, and Others), By Mode, By Services, And Trend Analysis From 2012 To 2022
出版日期: 2016年03月06日 內容資訊: 英文 78 Pages
簡介

全球藥物研發的資訊學市場預計至2022年達到65億4,810萬美元。由於藥物開發使技術性進化的產品增加,一般認為該市場今後將大幅成長。由於早期的ADME/毒性篩檢的In Silico模式的使用擴大,從傳統的體外藥物開發大幅度轉移到電腦支援的藥物設計。

本報告提供全球藥物研發的資訊學市場現狀與至2022年的成長預測,各工作流程、各手法、各類服務趨勢,以及主要企業的簡介等彙整。

第1章 調查方法與調查範圍

第2章 摘要整理

第3章 產業預測

  • 市場區隔
  • 市場規模與成長預測
    • 促進要素
    • 阻礙要素
  • 藥物研發資訊學市場趨勢
  • 主要的機會
  • 產業分析:波特
  • PESTEL分析

第4章 各工作流程市場預測

  • 藥物研發
    • 藥物研發
    • 鑑定及驗證
    • 領導生成
  • 開發
    • 開發
    • 先導藥物最適化
    • FHD準備
    • 第IA相
    • 第IB/2相

第5章 各手法預測

  • 內部
  • 外包

第6章 各類服務預測

  • 分子模擬
  • 序列分析平台
  • 對接
  • 臨床實驗資料管理
  • 其他

第7章 各地區預測

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第8章 競爭環境

  • ChemAxon
  • GVK Biosciences
  • Jubilant Biosys
  • Selvita
  • Certara
  • Infosys
  • Albany Molecular Research Inc.
  • BoehringerIngelheimGmBh
  • DiscoverX
  • Charles River Laboratories
  • Covance

圖表

目錄
Product Code: 978-1-68038-749-0

Global drug discovery informatics market is anticipated to reach USD 6,548.1 million by 2022, according to a new report by Grand View Research Inc.Ongoing improvement incomputational technology is anticipated to drive the adoption of in-silicotherapeutic product discovery models thus, influencing sectorprogress over the forecast period.

Drug discovery informatics industry is estimated to witness lucrative growth over the forecast period majorly due to, the rising number of technologically advanced products in the field of drug development. Significant shift observed from traditional in-vitro drug developmentto computer aided drug designing, as costly failures of late drug development increases the use of in-silico models for early ADME/Toxicity screening is anticipated to propel progress in this sector.

Furthermore, R&D carried out in the field of information technology for the facilitation of analytics and visualization applications that enable data aggregation and processing is attributive for driving growth in this market through to 2022.

Further key findings from the report suggest:

Discovery informatics dominated accounting for the largest share of the market in 2014 owing to presence of substantial number of in-silico tools and databases in this segment, which aid the process of lead identification and validation.

Development informatics is anticipated to witness substantial progress in the coming years because of upcoming development in the sub segments that involve clinical trial data management services and softwares.

As per the mode of informatics solutions, outsourced informatics accounted for a large share in 2014 because of the high capital costs associated with in-house services for drug discovery IT solutions. Furthermore, with the rise in collaborations andlead compound discovery projects between IT market participants and pharmaceutical companies, outsourcedservicesare expected to continue to register lucrative demand in the coming years.

Sequence analysis based informatics was the largest service segmentin 2014 and is expected to maintain its dominance through to 2022. High R&D investment for genomic sequencing as this being the initial step for target as well as lead identification is expected to support in projected progress.Moreover, enhancement in NGS technology coupled with growing adoption rate due to reduction in cost of sequencing per base pairare prime factors responsible in driving demand for NGS sequence analysis technology solutions thus impacting segment growth positively.

North America accounted for the largest share of revenue generated in 2014. This large share can be accounted for by the presence of an enhanced technological framework, high R&D investment in information technology; growing adoption of computational novel entities discovery paradigms are the major factors attributive for region's dominant market position.

However, Asia Pacific is projected to register the fastest growth over the forecast period owing to technological developments carried out in the developing economies of this region in order to promote introduction of novel drug targets and chemical entities for reduction of chronic disease burden

Key players operating in this market includeGVK Biosciences, Boehringer Ingelheim GmBh, Albany Molecular Research Inc, Certara, Infosys, DiscoverX, Selvita, Jubilant Biosys, Collaborative Drug Discovery Inc., Charles River Laboratories, ChemAxon, and Novo Informatics.

These entities are involved in collaborations with therapeutic product discovery and development laboratories, clinical research organizations, academic institutes, pharmaceutical companies, and clinical research institutes in order to gain access in the competitive industry.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Scope & Assumptions
  • 1.3. List of Data Sources

Chapter 2. Executive Summary

Chapter 3. Drug Discovery InformaticsIndustry Outlook

  • 3.1. Market Segmentation
  • 3.2. Market Size and Growth Prospects
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Drug discovery informaticsMarket Dynamics
  • 3.4. Key Opportunities Prioritized, 2014
  • 3.5. Industry Analysis -Porter's
  • 3.6. Drug discovery informaticsMarket PESTEL Analysis

Chapter 4. Drug Discovery InformaticsOutlook, by Workflow

  • 4.1. Discovery Informatics
    • 4.1.1. Discovery Informatics Market Estimates and Forecasts, 2012 - 2022 (USD Million)
    • 4.1.2. Identification & Validation Informatics Assay Development Informatics
      • 4.1.2.1. Identification & Validation Informatics Assay Development Informatics Market Estimates and Forecasts, 2012 - 2022 (USD Million)
    • 4.1.3. Lead Generation Informatics
      • 4.1.3.1. Lead Generation Informatics Market Estimates and Forecasts, 2012 - 2022 (USD Million)
  • 4.2. Development Informatics
    • 4.2.1. Development Informatics Market Estimates and Forecasts, 2012 - 2022 (USD Million)
    • 4.2.2. Lead Optimization
      • 4.2.2.1. Lead Optimization Market Estimates and Forecasts, 2012 - 2022 (USD Million)
    • 4.2.3. FHD Preparation
      • 4.2.3.1. FHD Preparation Market Estimates and Forecasts, 2012 - 2022 (USD Million)
    • 4.2.4. Phase IA Informatics
      • 4.2.4.1. Phase IA Informatics Market Estimates and Forecasts, 2012 - 2022 (USD Million)
    • 4.2.5. Phase IB/2 Informatics
      • 4.2.5.1. Phase IB?2 Informatics Market Estimates and Forecasts, 2012 - 2022 (USD Million)

Chapter 5. Drug Discovery InformaticsOutlook, By Mode

  • 5.1. In-house Informatics
    • 5.1.1. In-house Informatics Market Estimates and Forecasts, 2012 - 2022 (USD Million)
  • 5.2. Outsourced Informatics
    • 5.2.1. Outsourced Informatics Market Estimates and Forecasts, 2012 - 2022 (USD Million)

Chapter 6. Drug Discovery InformaticsOutlook, By Services

  • 6.1. Molecular Modeling
    • 6.1.1. Molecular Modeling Market Estimates and Forecasts, 2012 - 2022 (USD Million)
  • 6.2. Sequence Analysis Platforms
    • 6.2.1. Sequence AnalysisPlatforms Market Estimates and Forecasts, 2012 - 2022 (USD Million)
  • 6.3. Docking
    • 6.3.1. Docking Market Estimates and Forecasts, 2012 - 2022 (USD Million)
  • 6.4. Clinical Trial Data Management
    • 6.4.1. Clinical Trial Data ManagementMarket Estimates and Forecasts, 2012 - 2022 (USD Million)
  • 6.5. Other Services
    • 6.5.1. Other Services Market Estimates and Forecasts, 2012 - 2022 (USD Million)

Chapter 7. Drug discovery informaticsRegional Outlook (Revenue, USD Million, 2012 - 2022)

  • 7.1. North America
    • 7.1.1. U.S.
      • 7.1.1.1. U.S. drug discovery informaticsmarket, by workflow, 2012 - 2022 (USD Million)
      • 7.1.1.2. U.S. drug discovery informaticsmarket, by mode, 2012 - 2022 (USD Million)
      • 7.1.1.3. U.S. drug discovery informaticsmarket, by services type, 2012 - 2022 (USD Million)
    • 7.1.2. Canada
      • 7.1.2.1. Canadadrug discovery informaticsmarket, by workflow, 2012 - 2022 (USD Million)
      • 7.1.2.2. Canadadrug discovery informaticsmarket, by mode, 2012 - 2022 (USD Million)
      • 7.1.2.3. Canadadrug discovery informaticsmarket, by services, 2012 - 2022 (USD Million)
  • 7.2. Europe
    • 7.2.1. Germany
      • 7.2.1.1. Germanydrug discovery informaticsmarket, by workflow, 2012 - 2022 (USD Million)
      • 7.2.1.2. Germanydrug discovery informaticsmarket, by mode, 2012 - 2022 (USD Million)
      • 7.2.1.3. Germanydrug discovery informaticsmarket, by services, 2012 - 2022 (USD Million)
    • 7.2.2. UK
      • 7.2.2.1. UKdrug discovery informaticsmarket, by workflow, 2012 - 2022 (USD Million)
      • 7.2.2.2. UKdrug discovery informaticsmarket, by mode, 2012 - 2022 (USD Million)
      • 7.2.2.3. UKdrug discovery informaticsmarket, by services, 2012 - 2022 (USD Million)
  • 7.3. Asia Pacific
    • 7.3.1. China
      • 7.3.1.1. Chinadrug discovery informatics market, by workflow, 2012 - 2022 (USD Million)
      • 7.3.1.2. Chinadrug discovery informaticsmarket, by mode, 2012 - 2022 (USD Million)
      • 7.3.1.3. Chinadrug discovery informaticsmarket, by services, 2012 - 2022 (USD Million)
    • 7.3.2. Japan
      • 7.3.2.1. Japandrug discovery informaticsmarket, by workflow, 2012 - 2022 (USD Million)
      • 7.3.2.2. Japandrug discovery informaticsmarket, by mode, 2012 - 2022 (USD Million)
      • 7.3.2.3. Japandrug discovery informaticsmarket, by services, 2012 - 2022 (USD Million)
  • 7.4. Latin America
    • 7.4.1. Brazil
      • 7.4.1.1. Brazildrug discovery informatics market, by workflow, 2012 - 2022 (USD Million)
      • 7.4.1.2. Brazildrug discovery informaticsmarket, by mode, 2012 - 2022 (USD Million)
      • 7.4.1.3. Brazildrug discovery informaticsmarket, by services, 2012 - 2022 (USD Million)
  • 7.5. MEA
    • 7.5.1. South Africa
      • 7.5.1.1. South Africadrug discovery informaticsmarket, by workflow, 2012 - 2022 (USD Million)
      • 7.5.1.2. South Africadrug discovery informaticsmarket, by mode, 2012 - 2022 (USD Million)
      • 7.5.1.3. South Africadrug discovery informaticsmarket, by services, 2012 - 2022 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. ChemAxon
    • 8.1.1. Company Overview
    • 8.1.2. Revenue Analysis
    • 8.1.3. Product Benchmarking
    • 8.1.4. Strategic Development
  • 8.2. GVK Biosciences
    • 8.2.1. Company Overview
    • 8.2.2. Revenue Analysis
    • 8.2.3. Product Benchmarking
    • 8.2.4. Strategic Development
  • 8.3. Jubilant Biosys
    • 8.3.1. Company Overview
    • 8.3.2. Revenue Analysis
    • 8.3.3. Product Benchmarking
    • 8.3.4. Strategic Development
  • 8.4. Selvita
    • 8.4.1. Company Overview
    • 8.4.2. Revenue Analysis
    • 8.4.3. Product Benchmarking
    • 8.4.4. Strategic Development
  • 8.5. Certara
    • 8.5.1. Company Overview
    • 8.5.2. Revenue Analysis
    • 8.5.3. Product Benchmarking
    • 8.5.4. Strategic Development
  • 8.6. Infosys
    • 8.6.1. Company Overview
    • 8.6.2. Revenue Analysis
    • 8.6.3. Product Benchmarking
    • 8.6.4. Strategic Development
  • 8.7. Albany Molecular Research Inc.
    • 8.7.1. Company Overview
    • 8.7.2. Revenue Analysis
    • 8.7.3. Product Benchmarking
    • 8.7.4. Strategic Development
  • 8.8. BoehringerIngelheimGmBh
    • 8.8.1. Company Overview
    • 8.8.2. Revenue Analysis
    • 8.8.3. Product Benchmarking
    • 8.8.4. Strategic Development
  • 8.9. DiscoverX
    • 8.9.1. Company Overview
    • 8.9.2. Revenue Analysis
    • 8.9.3. Product Benchmarking
    • 8.9.4. Strategic Development
  • 8.10. Charles River Laboratories
    • 8.10.1. Company Overview
    • 8.10.2. Revenue Analysis
    • 8.10.3. Product Benchmarking
    • 8.10.4. Strategic Development
  • 8.11. Covance
    • 8.11.1. Company Overview
    • 8.11.2. Revenue Analysis
    • 8.11.3. Product Benchmarking
    • 8.11.4. Strategic Development

List of Tables

  • 1. Drug discovery informaticsmarket - Industry Snapshot & Key Buying Criteria, 2012 - 2022
  • 2. Global drug discovery informatics market, by workflow, 2012 - 2022 (USD Million)
  • 3. Global drug discovery informatics market, by mode, 2012 - 2022 (USD Million)
  • 4. Global drug discovery informatics market, by services, 2012 - 2022 (USD Million)
  • 5. Global drug discovery informaticsmarket, by region, 2012 - 2022 (USD Million)
  • 6. Drug discovery informatics- Key market driver analysis
  • 7. Drug discovery informatics- Key market restraint analysis
  • 8. North America drug discovery informatics market, by workflow, 2012 - 2022 (USD Million)
  • 9. North America discovery informatics market, by workflow, 2012 - 2022 (USD Million)
  • 10. North America development informatics market, by workflow, 2012 - 2022 (USD Million)
  • 11. North America drug discovery informatics market, by mode, 2012 - 2022 (USD Million)
  • 12. North America drug discovery informatics market, by services, 2012 - 2022 (USD Million)
  • 13. U.S.drug discovery informatics market, by workflow, 2012 - 2022 (USD Million)
  • 14. U.S.discovery informatics market, by workflow, 2012 - 2022 (USD Million)
  • 15. U.S.development informatics market, by workflow, 2012 - 2022 (USD Million)
  • 16. U.S.drug discovery informatics market, by mode, 2012 - 2022 (USD Million)
  • 17. U.S.drug discovery informatics market, by services, 2012 - 2022 (USD Million)
  • 18. Canadadrug discovery informatics market, by workflow, 2012 - 2022 (USD Million)
  • 19. Canadadiscovery informatics market, by workflow, 2012 - 2022 (USD Million)
  • 20. Canadadevelopment informatics market, by workflow, 2012 - 2022 (USD Million)
  • 21. Canadadrug discovery informatics market, by mode, 2012 - 2022 (USD Million)
  • 22. Canadadrug discovery informatics market, by services, 2012 - 2022 (USD Million)
  • 23. Europedrug discovery informatics market, by workflow, 2012 - 2022 (USD Million)
  • 24. Europediscovery informatics market, by workflow, 2012 - 2022 (USD Million)
  • 25. Europedevelopment informatics market, by workflow, 2012 - 2022 (USD Million)
  • 26. Europedrug discovery informatics market, by mode, 2012 - 2022 (USD Million)
  • 27. Europedrug discovery informatics market, by services, 2012 - 2022 (USD Million)
  • 28. Germanydrug discovery informatics market, by workflow, 2012 - 2022 (USD Million)
  • 29. Germanydiscovery informatics market, by workflow, 2012 - 2022 (USD Million)
  • 30. Germanydevelopment informatics market, by workflow, 2012 - 2022 (USD Million)
  • 31. Germanydrug discovery informatics market, by mode, 2012 - 2022 (USD Million)
  • 32. Germanydrug discovery informatics market, by services, 2012 - 2022 (USD Million)
  • 33. UKdrug discovery informatics market, by workflow, 2012 - 2022 (USD Million)
  • 34. UKdiscovery informatics market, by workflow, 2012 - 2022 (USD Million)
  • 35. UKdevelopment informatics market, by workflow, 2012 - 2022 (USD Million)
  • 36. UKdrug discovery informatics market, by mode, 2012 - 2022 (USD Million)
  • 37. UKdrug discovery informatics market, by services, 2012 - 2022 (USD Million)
  • 38. Asia Pacificdrug discovery informatics market, by workflow, 2012 - 2022 (USD Million)
  • 39. Asia Pacificdiscovery informatics market, by workflow, 2012 - 2022 (USD Million)
  • 40. Asia Pacificdevelopment informatics market, by workflow, 2012 - 2022 (USD Million)
  • 41. Asia Pacificdrug discovery informatics market, by mode, 2012 - 2022 (USD Million)
  • 42. Asia Pacificdrug discovery informatics market, by services, 2012 - 2022 (USD Million)
  • 43. Chinadrug discovery informatics market, by workflow, 2012 - 2022 (USD Million)
  • 44. Chinadiscovery informatics market, by workflow, 2012 - 2022 (USD Million)
  • 45. Chinadevelopment informatics market, by workflow, 2012 - 2022 (USD Million)
  • 46. Chinadrug discovery informatics market, by mode, 2012 - 2022 (USD Million)
  • 47. Chinadrug discovery informatics market, by services, 2012 - 2022 (USD Million)
  • 48. Japandrug discovery informatics market, by workflow, 2012 - 2022 (USD Million)
  • 49. Japandiscovery informatics market, by workflow, 2012 - 2022 (USD Million)
  • 50. Japandevelopment informatics market, by workflow, 2012 - 2022 (USD Million)
  • 51. Japandrug discovery informatics market, by mode, 2012 - 2022 (USD Million)
  • 52. Japandrug discovery informatics market, by services, 2012 - 2022 (USD Million)
  • 53. Latin Americadrug discovery informatics market, by workflow, 2012 - 2022 (USD Million)
  • 54. Latin Americadiscovery informatics market, by workflow, 2012 - 2022 (USD Million)
  • 55. Latin Americadevelopment informatics market, by workflow, 2012 - 2022 (USD Million)
  • 56. Latin Americadrug discovery informatics market, by mode, 2012 - 2022 (USD Million)
  • 57. Latin Americadrug discovery informatics market, by services, 2012 - 2022 (USD Million)
  • 58. Brazildrug discovery informatics market, by workflow, 2012 - 2022 (USD Million)
  • 59. Brazildiscovery informatics market, by workflow, 2012 - 2022 (USD Million)
  • 60. Brazildevelopment informatics market, by workflow, 2012 - 2022 (USD Million)
  • 61. Brazildrug discovery informatics market, by mode, 2012 - 2022 (USD Million)
  • 62. Brazildrug discovery informatics market, by services, 2012 - 2022 (USD Million)
  • 63. MEAdrug discovery informatics market, by workflow, 2012 - 2022 (USD Million)
  • 64. MEAdiscovery informatics market, by workflow, 2012 - 2022 (USD Million)
  • 65. MEAdevelopment informatics market, by workflow, 2012 - 2022 (USD Million)
  • 66. MEAdrug discovery informatics market, by mode, 2012 - 2022 (USD Million)
  • 67. MEAdrug discovery informatics market, by services, 2012 - 2022 (USD Million)
  • 68. South Africadrug discovery informatics market, by workflow, 2012 - 2022 (USD Million)
  • 69. South Africadiscovery informatics market, by workflow, 2012 - 2022 (USD Million)
  • 70. South Africadevelopment informatics market, by workflow, 2012 - 2022 (USD Million)
  • 71. South Africadrug discovery informatics market, by mode, 2012 - 2022 (USD Million)
  • 72. South Africadrug discovery informatics market, by services, 2012 - 2022 (USD Million)

List of Figures

  • 1. Drug discovery informatics market segmentation
  • 2. Global drug discovery informatics market, 2012 - 2022 (USD Million)
  • 3. Drug discovery informaticsmarket dynamics
  • 4. Key opportunities prioritized, 2014
  • 5. Drug discovery informaticsmarket - Porter's Analysis
  • 6. Drug discovery informaticsmarket - PESTEL analysis
  • 7. Drug discovery informaticsrevenue share, by workflow, 2014 & 2022
  • 8. Discovery informaticsmarket , 2012 - 2022 (USD Million)
  • 9. Identification & validation informatics assay development informaticsmarket , 2012 - 2022 (USD Million)
  • 10. Lead generation informaticsmarket , 2012 - 2022 (USD Million)
  • 11. Developmentinformaticsmarket , 2012 - 2022 (USD Million)
  • 12. Lead optimization market , 2012 - 2022 (USD Million)
  • 13. FHD preparation market , 2012 - 2022 (USD Million)
  • 14. Phase IAinformaticsmarket , 2012 - 2022 (USD Million)
  • 15. Phase IB/2 informaticsmarket , 2012 - 2022 (USD Million)
  • 16. Drug discovery informaticsrevenue share, by mode, 2014 & 2022
  • 17. In-house informaticsmarket , 2012 - 2022 (USD Million)
  • 18. Outsourced informaticsmarket , 2012 - 2022 (USD Million)
  • 19. Drug discovery informatics revenue share, by services, 2014 & 2022
  • 20. Sequence analysis platformsmarket , 2012 - 2022 (USD Million)
  • 21. Molecular modelingmarket , 2012 - 2022 (USD Million)
  • 22. Dockingmarket , 2012 - 2022 (USD Million)
  • 23. Clinical trial data management market , 2012 - 2022 (USD Million)
  • 24. Other services market , 2012 - 2022 (USD Million)
  • 25. Drug discovery informaticsrevenue share, by region, 2014 & 2022
  • 26. North Americadrug discovery informaticsmarket, 2012 - 2022 (USD Million)
  • 27. U.S.drug discovery informaticsmarket, 2012 - 2022 (USD Million)
  • 28. Canada drug discovery informaticsmarket, 2012 - 2022 (USD Million)
  • 29. Europe drug discovery informaticsmarket, 2012 - 2022 (USD Million)
  • 30. Germanydrug discovery informaticsmarket, 2012 - 2022 (USD Million)
  • 31. UKdrug discovery informaticsmarket, 2012 - 2022 (USD Million)
  • 32. Francedrug discovery informaticsmarket, 2012 - 2022 (USD Million)
  • 33. Asia Pacific drug discovery informaticsmarket, 2012 - 2022 (USD Million)
  • 34. Chinadrug discovery informaticsmarket, 2012 - 2022 (USD Million)
  • 35. Japandrug discovery informaticsmarket, 2012 - 2022 (USD Million)
  • 36. Latin Americadrug discovery informaticsmarket, 2012 - 2022 (USD Million)
  • 37. Brazildrug discovery informaticsmarket, 2012 - 2022 (USD Million)
  • 38. MEAdrug discovery informaticsmarket, 2012 - 2022 (USD Million)
  • 39. South Africadrug discovery informaticsmarket, 2012 - 2022 (USD Million)
Back to Top